Cochlear Limited Reports 5% Revenue Growth in H1 FY2025

Cochlear Limited ( (AU:COH) ) has issued an update.

Cochlear Limited reported a 5% increase in sales revenue for the first half of the fiscal year 2025, reaching $1,170 million, despite a decline in services revenue. The company’s cochlear implant and acoustics segments showed significant growth, while services revenue experienced a decline due to high customer satisfaction with existing products and economic factors in the US. Cochlear plans to release new products, including a next-generation cochlear implant, in mid-2025, which may further impact its market position positively.

More about Cochlear Limited

Cochlear Limited operates in the medical devices industry, specializing in cochlear and acoustic implants. The company focuses on providing solutions for hearing loss through innovative implant technologies, catering to both developed and emerging markets.

YTD Price Performance: 5.53%

Average Trading Volume: 86

Technical Sentiment Consensus Rating: Hold

Current Market Cap: $12.6B

For a thorough assessment of COH stock, go to TipRanks’ Stock Analysis page.